THE UK Medicines and Healthcare products Regulatory Agency has published a review of reboxetine, which found that the drug is statistically significantly more effective than placebo in the treatment of patients with severe clinical depression.
Article by Reboxetine – Google Blog Search. Read entire story here.
News and insights about GAD, depression, phobias, OCD and panic attacks